Statement from FDA Commissioner Scott Gottlieb, M.D., and Janet Woodcock, M.D., director of the Center for Drug Evaluation and Research on the agency ’s list of known nitrosamine-free valsartan and ARB class medicines, as part of agency’s ongoing efforts to resolve ongoing safety issue

FDA announces list of nitrosamine-free ARB medications confirmed by the agency to help patients and healthcare providers
Source: Food and Drug Administration - Category: American Health Source Type: news